< back to Management Team

Kathleen L. Mattis, MBA
Ms. Mattis has served as Chief Financial Officer of Neuronascent from November 2006 to 2010 and Secretary to the Board of Directors since May 2004. From 2004 to 2006, she was the principal business advisor for Neuronascent’s fiscal operations. Prior to joining Neuronascent, since 2003, she served as the Chief Financial Officer of J. Craig Venter Institute. Previously, she was Vice President of Finance for Neuralstem, Inc.; Controller at Celera Genomics; Founder, Vice President of Finance and Controller for ARIAD Pharmaceuticals, Inc. and Director of Finance for Centocor, Inc. She also served as Controller of Novo Nordisk Pharmaceuticals, Inc. after holding multiple financial management positions at Squibb Corporation in Princeton, NJ and Kraft, Inc. in Chicago, IL. Ms. Mattis has a BS from Drexel University and MBA from the Wharton School of University of Pennsylvania.

 

 


  » Home
» News & Events
» Contact Us
ABOUT US
Management Team
Directors & Advisors
Collaborators
Memberships
TECHNOLOGY
Neurogenesis & Neuron Regeneration
Drug Discovery
Intellectual Property
R&D PROGRAMS
Alzheimer's Disease
Depression
Parkinson's Disease
Down Syndrome
Ischemia
Hibernation and Ischemia
  © 2016 NeuroNascent, Inc. - All Rights Reserved
This website contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as “would,” “may,” “will,” “expects,” and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this site and involve risks and uncertainties that could cause actual results to differ materially from current expectations.